
|Slideshows|July 5, 2017
How Safe is Long-term Antiplatelet Rx After a Vascular Event?
Author(s)Veronica Hackethal, MD
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
REGENXBIO's MPS II Gene Therapy RGX-121 Hit With CRL
2
Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis
3
AGNOS Study Results Demonstrate Ofatumumab’s Impact on Neurofilament Light, GFAP
4
Rethinking Multiple Sclerosis Clinical Course Classifications in the Modern Era: Daniel Ontaneda, MD, PhD
5








